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SUMMARY
Neurexins are key synaptic organizers that are
expressed in thousands of alternatively spliced
isoforms. Because transsynaptic neurexin interac-
tions with different postsynaptic molecules are
largely isoform dependent, a cell type-level census
of different neurexin isoforms could predict molecu-
lar interactions relating to synapse identity and
function. Using single-cell transcriptomics to study
the origin of neurexin diversity in multiple murine
mature and embryonic cell types, we have discov-
ered shared neurexin expression patterns in devel-
opmentally related cells. By comparing neurexin
profiles in immature embryonic neurons, we show
that neurexin profiles are specified during early
development and remain unchanged throughout
neuronal maturation. Thus, our findings reveal onto-
genetic stability and provide a cell type-level census
of neurexin isoform expression in the cortex.
INTRODUCTION
Frequently implicated in neuropsychiatric disorders such as
autism, neurexins (Nrxn1–Nrxn3) are broadly expressed syn-
apse-organizing molecules that are expressed in thousands of
alternatively spliced isoforms (Treutlein et al., 2014; Schreiner
et al., 2014). Different isoforms restrict and rank transsynaptic
binding preference among the many synaptic neurexin-binding
partners (de Wit and Ghosh, 2016; S€udhof, 2017). In one specific
example, single exon cassette excision or inclusion at alternative
splicing site-4 (ASS4) determines neurexin binding preference to
postsynaptic latrophilins andLRRTMs (exon inclusion) or cerebel-
lins (exon exclusion). Complemented by activity-dependent
splicing programs (Iijima et al., 2011; Shapiro-Reznik et al.,
2012; Ding et al., 2017) and heparan sulfate modulation (Zhang
et al., 2018), neurexin isoformsmay render specificsynapticprop-
erties to different cell types (Aoto et al., 2013; Anderson et al.,
2015; Traunm€uller et al., 2016). Transcriptomic analysis of rela-
tively few isoforms and cell types has begun to reveal that cell
type-specific expression of neurexins may be important for brain
function (Traunm€uller et al., 2016; Fuccillo et al., 2015; Nguyen
et al., 2016). For example, although both are GABAergic types,
hippocampal PV and CCK interneurons (INs) expressed different
isoforms (Fuccillo et al., 2015). Most notably, the single exon
cassette at ASS3 was uniformly spliced in by PV-INs but spliced
out by CCK-INs. Although functional relevance for this exon
cassette remains elusive, such a striking difference in synapse-
organizing molecules is anticipated by diametrically different
use of presynaptic Ca2+ channels and release-modulating recep-
tors by PV-IN and CCK-IN cells (Freund and Katona, 2007; e.g.,
P/Q-type and m-opioid receptors in PV-INs versusN-type and en-
docannabinoid receptors in CCK-INs). Conversely, in prefrontal
cortical INs, functional neurexin phenotypes are better under-
stood: genetic deletion of all neurexins in PV-INs decreased
synapse numbers without affecting GABA release in surviving
synapses (Chen et al., 2017). In contrast, in SST-INs, the same
manipulation impaired presynaptic Ca2+ influx without changing
synapse numbers (Chen et al., 2017). These phenotypes, how-
ever, have not been attributed to specific neurexin isoforms,
because neurexin expression has not been identified in these
cells. For someof the isoforms that havebeenexamined, neurexin
expression between INs versus glutamatergic pyramidal cells
(PCs) is also different. As a notable example, in hippocampus,
the single exon cassette at ASS4 was spliced in for all three neu-
rexins by PV-INs but consistently spliced out by PYRs (Nguyen
et al., 2016). The lack of this exon atNrxn3was found to be essen-
tial for long-term potentiation in CA1 PC synapses (Aoto et al.,
2013). Independently, the short beta-neurexin isoform conferred
endocannabinoid signaling to CA1 PC synapses (Anderson
et al., 2015). Given that hundreds of neuron types (Masland,
2004; Tasic et al., 2016, 2018) and thousandsof neurexin isoforms
(Treutlein et al., 2014; Schreiner et al., 2014) exist in the brain,
bridging thegapbetweenneurexin function andcircuit operations
requires a detailed map of cell type-specific isoform expression.
RESULTS
Neurexin Expression and Alternative Splicing in Mature
Neurons
To examine neurexin isoforms, we analyzed one comprehensive
RNA sequencing (RNA-seq) dataset of cortical cell types
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generated by the Allen Institute (Tasic et al., 2018), representing
19,439 single cells from 115 cortical neuron types (Figure 1A).
According to cell type identity, these cells expressed specific
combinations of development-related marker genes (Wamsley
and Fishell, 2017; Lim et al., 2018; Telley et al., 2016): medial
ganglionic eminence-associated Lhx6, Satb1, and Sox6; caudal
ganglionic eminence- and preoptic area-associated Prox1 and
Htr3a; and pallial ventricular zone-associated Neurod1 and
Neurod2. On the basis of marker expression, we distinguished
Lhx6-expressing INs (hereafter referred to as Lhx6+-INs; Liodis
et al., 2007), Prox1-expressing INs (Prox1+-INs; Miyoshi et al.,
2015), andNeurod2-expressing PCs (Telley et al., 2016). A single
A
B
C
Figure 1. Alternative Splicing of Neurexins in Mature Neurons
(A) Violin plots show averaged developmental marker-gene expression (Neurod1 through Htr3a) in different cortical cell types (columns). Cell types were as
published by the Allen Institute (Tasic et al., 2018) and grouped on the basis of Lhx6, Prox1, and Neurod2 expression. Neurexins (Nrxn1 through Nrxn3) were
consistently expressed in all neuron types.
(B) Upper panel: exon structure of Nrxn1. Purple blocks represent exons, and curved lines represent alternative exon splicing events. Intronic segments are
disproportionally shortened for clarity. Conserved alternative splicing sites (ASS1–ASS6) and individual exons (1–24) are labeled above and below the plot,
respectively. Lower panel: bar plots show averaged and normalized alternative splicing of ASS1–ASS6 of Nrxn1 in Lhx6+, Prox1+, and PC cell classes. For each
cell class, exon inclusion (‘‘in,’’ upward bars) and exclusion (‘‘out,’’ downward bars) isoforms sum to 1. Cell type- and exon-level data are shown in Figures S2–S4
and S6. Data represent the mean and SEM.
(C) Upper panel: exon structure of Nrxn3. Lower panel: bar plots show averaged and normalized alternative splicing of ASS1 through ASS6 of Nrxn3 in Lhx6+,
Prox1+, and PC cell classes.
See also Figures S1–S6.
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IN type co-expressed both Lhx6 and Prox1 (labeled ‘‘Lamp5
Lhx6’’ in Tasic et al., 2018) and was therefore classified as
neither IN class. We found thatNrxn1,Nrxn2, andNrxn3were ex-
pressed in all cell types (in 19,437, 19,028, and 19,086 cells out of
19,439 total cells examined, respectively). However, Nrxn2
expression was >10-fold lower than Nrxn1 and Nrxn3, and its
exon-junction coverage was insufficient for splicing analysis
(Figure S1). Therefore, further analyses focused on Nrnx1 and
Nrxn3. These genes contain multiple different start sites for tran-
scription and six canonical alternative splicing sites (ASS1–6;
Figures 1B and 1C; Treutlein et al., 2014; Schreiner et al.,
2014). A combination of most neurexin isoform variants being
un-annotated and the independence of alternative splicing
behavior at separate canonical splicing sites (Treutlein et al.,
2014; Schreiner et al., 2014) posed challenges for current
splice-aware algorithms in analyzing neurexin isoforms. There-
fore, we developed and validated an algorithm for analyzing neu-
rexin canonical alternative splicing (STAR Methods; Figure S1).
Where alternative splicing involves multiple exons and mini-
exons, detection of either exon ‘‘in’’ junction is counted as
inclusion, and specific detection of exon ‘‘out’’ junction is
counted as exclusion, because we did not detect any cell
type-dependent difference within these (Figure S2).
By examining alternative splicing in Lhx6+-INs, Prox1+-Ins,
and PCs, we made the following observations (Figures 1B
and 1C; Figure S3): (1) in all three classes, Nrxn1-ASS1 exons
were invariably spliced in (‘‘in’’; upward bars), whereas Nrxn3-
ASS1 exons were dominantly but not exclusively spliced in;
(2) Nrxn1-ASS2 exons were spliced-out (‘‘out’’; downward
bars) in INs but variably used in PCs, whereas Nrxn3-ASS2
exons were invariably spliced out; (3) Nrxn1- and Nrxn3-ASS3
exons were invariably spliced in in Lhx6+-INs and PCs but
spliced out in Prox1+-INs; (4) Nrxn1-ASS6 exons were spliced
out in all INs and variably used in PCs, whereas Nrxn3-ASS6
exons were variably spliced out in all types; (5) Nrxn1- and
Nrxn3-ASS4 exons were spliced-in in INs but variably spliced
out in PCs in an increasing fashion from layer 2/3 to layer 6
(although note that some of the deep-layer PCs retained a
preference for splice-in; see Figure S3); and (6) in all cell clas-
ses, ASS5 exons were variably used. In additional analyses
we show that Nrxn1-ASS4, Nrxn1-ASS5, Nrxn3-ASS1, Nrxn3-
ASS4, and Nrxn3-ASS5 in and out isoforms were variably
expressed within each cell type (Figure S4). In contrast,
Nrxn1-ASS6 in and out isoforms were co-expressed only by
PCs but not by INs. Furthermore, we found that expression of
known neurexin alternative splicing factors did not fully explain
the found neurexin patterns (Figure S5). In contrast, secreted
neurexin ligands and neuronal pentraxins were expressed in a
cell type-specific manner (Figure 2).
Given these striking patterns of neurexin alternative splicing
and that cells that belong to Lhx6+-IN, Prox1+-IN, and PC clas-
ses are separately related through development (Wamsley and
Fishell, 2017; Lim et al., 2018; Telley et al., 2016; Miyoshi et al.,
2015), we examined whether key developmental markers might
mirror neurexin patterns. We performed principal-component
analysis (PCA) on the basis of expression of Neurod1, Neurod2,
Lhx6, Satb1, Sox6, Htr3a, and Prox1 in each cell type, which as
expected separately clustered Lhx6+-IN, Prox1+-IN, and PC
classes (Figure 3A; Figure S5). Presumably because of the
shared expression of Lhx6 and Prox1, the ‘‘Lamp5 Lhx6’’ type
clustered in between Lhx6+ and Prox1+-INs. Interestingly, the
same PCA patterns emerged when using neurexin alternative
splicing levels (relative amounts of in and out for the total of
12 alternative splicing sites of Nrxn1 and Nrxn3; Figure 3B; Fig-
ure S5), which demonstrated that neurexins correlate extremely
well with developmental markers at predicting developmental
Figure 2. Cell Type-Specific Expression of Secreted Neurexin Ligands and Neuronal Pentraxins
Violin plots show averaged gene expression levels of secreted neurexin ligands and neuronal pentraxins, listed on left. Neurexophilins bind to the LNS2 domain of
neurexins independent of alternative splicing at ASS2. Cerebellins, Cbln1 and Cbln2, bind all neurexins, but only those containing an exon insert at ASS4.
C1q-likes, C1ql2 and C1ql3, bind neurexin-3 via an ASS5 sequence. Unrelated to neurexins, neuronal pentraxins, Nptx1, Nptx2, and Nptxr, show expression
patterns similar to neurexin isoforms (for reviews, see Matsuda, 2017; S€udhof, 2017; Yuzaki, 2018). See also Figure S5.
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origin. Note, however, that three layer 5 PC types (i.e., L5 NP
VISp Trhr Met, L5 NP VISp Trhr Cpne7, and L5 NP ALM Trhr
Nefl) clustered together with Lhx6+-INs because of their domi-
nant exon inclusion at both Nrxn1 and Nrxn3 ASS4 (Figure S3).
In this analysis, the ‘‘Lamp5 Lhx6’’ type displayed a profile that
was more similar to Prox1+-IN than Lhx6+-IN classes. Finally,
we performed PCA on the basis of secreted neurexin ligand
expression, which despite showing cell type-specific expression
patterns (Figure 2) did not show a clear separation of classes
(Figure 3C; Figure S5).
Neurexin Expression and Alternative Splicing in
Embryonic Neurons
This finding led us to the hypothesis that neurexin profiles are
defined in early development and remain unchanged during neu-
ral maturation. To test this hypothesis, we needed to go beyond
previous reports on neurexin expression in the developing brain
(P€uschel and Betz, 1995; Jenkins et al., 2016; Lai et al., 2016;
Harkin et al., 2017), and generate single-cell data from embry-
onic Lhx6+-IN, Prox1+-IN, and PC cells with sufficient read depth
(150 bp long and more than 10 million paired-end reads per cell)
to detect single isoform differences. To identify such cells, we
used the Lhx6-Cre::Ai14, Htr3a-Cre::Ai14, and Nex-Cre::Ai14
transgenic reporter lines, respectively. Using patch-clamp
recording, we identified migrating tdTomato+ neurons in dorsal
and medial pallium as well as in the subpallium (at E17.5–18.5)
and collected their mRNA for next-generation sequencing (Fo¨ldy
et al., 2016; Figure 4A; Figure S7). Half of these cells (66 of 136)
were tested for their electrophysiological properties, which re-
vealed that action potentials could be elicited in 52 of 66 cells,
confirming that these cells were developing neurons (Figure S7).
Because cell labeling in the Htr3a-Cre::Ai14 line is not exclusive
to Prox1+ cells but has been shown to include Lhx6+ type
SST-INs (Chittajallu et al., 2013) and PCs (including Cajal-
Retzius cells; Chameau et al., 2009), we further confirmed these
cells’ identity by analyzing expression of cell type-specific
marker genes and transcription factors, as a more accurate
readout for single-cell identity (Figures 4C and 4D; see STAR
Methods for details on cell classification). In this manner, we
identified four embryonic cell (EC) classes in our data: Lhx6+
ECs (hereafter referred to as Lhx6+-EC),Htr3a/Prox1-expressing
cells (Prox1+-EC), Ndnf/Reln-expressing Cajal-Retzius cells
(CR-EC), and finally Neurod2-expressing embryonic glutamater-
gic PCs (PC-EC). We then examined neurexin expression
(Figures 4C and 4D; Figure S7) and found thatNrxn1was consis-
tently expressed in all ECs. In contrast, Nrxn3 was expressed in
all IN-EC cells, but only in some of the PC-ECs. Because most
Cajal-Retzius cells die during early postnatal stages, we did
not further analyze these cells.
Next, we analyzed neurexin alternative splicing. Specifically,
we examined if neurexin alternative splicing in embryonic
classes matches that found in mature neurons presumed to
derive from that classes. In this manner, we found remarkable
agreement between mature Lhx6+-IN and embryonic Lhx6+-
EC, between Prox1+-IN and Prox1+-EC, and between PC and
PC-EC, in all neurexin splice isoforms in both Nrxn1 and Nrxn3
(Figures 4E–4G; Figure S7). Regression analysis on neurexin
splice isoform profiles revealed high correlation coefficients
with strong statistical significance for all three mature versus
embryonic comparisons (R > 0.88 and adjusted p < 103 in all
cases; Figures 4H–4K). In contrast, regression analysis between
non-matching pairs, for examplemature Lhx6+-IN versus embry-
onic Prox1+-EC, resulted in non-significant correlations, with the
exception of the PCs versus Prox1+-EC comparison, which
showed a strong correlation (R = 0.8, adjusted p = 0.01;
Figure S7).
DISCUSSION
By analyzing neurexin profiles in single embryonic and adult
neurons, we show that neurexin alternative splicing profiles
are remarkably similar within, but different between, mature
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Figure 3. Alternative Splicing of Neurexins Correlates with Neurogenic Origin
(A) PCA plot shows clear separation of cell classes on the basis of developmental marker-gene expression (Neurod1 throughHtr3a). Cell types were as published
by the Allen Institute (Tasic et al., 2018) and grouped into classes based on the first identifier of their cell type labels. For cell type-level plots, see Figure S5.
Background color represents linear partitioning-based support vector machine (SVM) classification.
(B) PCA plot shows clear separation of cell classes on the basis of neurexin alternative splicing (Nrxn1 and Nrxn3, ASS1–ASS6).
(C) PCA plot based on secreted neurexin ligands.
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Figure 4. Alternative Splicing of Neurexins in Embryonic Neurons
(A) In acute embryonic brain slices, we identified neurons on the basis of tdTomato expression in Lhx6-Cre, Htr3a-Cre, and Nex-Cre driver lines and used
patch-clamp recording pipettes to aspirate their cytosolic mRNA for single-cell RNA sequencing.
(B) Violin plots show read number, mapping rate, and gene counts in single embryonic cell samples after sequencing and read alignment. In each cells, >10million
reads were generated to enable analysis of alternatively spliced isoforms.
(C) Heatmap shows normalized gene expression levels in single Lhx6+, Prox1+, Cajal-Retzius, and PC-classified embryonic cells (labeled Lhx6+-EC, Prox1+-EC,
CR-EC, and PC-EC, respectively; each column represents a single cell). First, cells were classified on the basis of gene expression related to vesicular GABA and
(legend continued on next page)
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GABAergic Lhx6+-INs, GABAergic Prox1+-INs, and glutamater-
gic PCs and that specific neurexin profiles are extremely well
correlated with marker genes of developmental origin. This
finding demonstrates a strong ontogenetic stability in alternative
splicing on the transcriptional level, whereas in many other
genes, this dynamically changes during development (Zhang
et al., 2016; Wamsley et al., 2018).
GABAergic PV-INs and SST-INs both express Lhx6 and form a
distinct population from Prox1+-INs yet display discrepant
phenotypes between PV-INs and SST-INs upon neurexin loss
of function (Chen et al., 2017). One possible explanation for
this discrepancy is the expression of different combinations of
neurexin isoforms. We now find that this scenario is unlikely,
by showing that cortical PV-INs and SST-INs express identical
neurexin profiles (Figures 1B and 1C; Figures S2 and S3).
Alternatively, different presynaptically secreted neurexin ligands
(e.g., cerebellins, C1q-likes, and neurexophilins) could alter
neurexin binding preferences to postsynaptic ligands and
modify synaptic function (S€udhof, 2017; Yuzaki, 2017). We find
evidence supporting this scenario, by showing differences in
neurexophilin, cerebellin, and c1q-like expression between
cortical PV-INs and SST-INs types (Figure 2). In addition, func-
tional differences between PV-INs and SST-INs types could be
further established by distinct postsynaptic neurexin-binding
molecules acting in trans or by heparan sulfate chains on neurex-
ins switching the mode of presynaptic neurexin function (Zhang
et al., 2018).
We also examined neurexin isoform specificity among gluta-
matergic PC cell types. Multiple lines of evidence suggest that
activity-dependent splicing at ASS3 and ASS4 is physiologi-
cally important (Iijima et al., 2011; Shapiro-Reznik et al., 2012;
Ding et al., 2017). At ASS3, we observed either complete
exon inclusion or excision, in a given cell or cell type, possibly
suggesting that alternative splicing at this site is strictly deter-
mined early in cell type ontogeny, during development. Along
similar lines, PCs appeared to display layer specificity of
ASS4 and ASS2 expression. Our expanded examination of 55
distinct PC types revealed a gradual shift of exon inclusion at
ASS4 (splice-in) in the most superficial PCs, to exclusion
(splice-out) in the deeper layer PCs, although some of the layer
5 and 6 PC types still displayed a clear preference for splice-in
(Figures S2 and S3). Nevertheless, superimposed upon this
layer specificity, within single cell types, we observed a mixture
of splice-in and splice-out at ASS4 (Figures S2 and S3), which
we believe could reflect dynamic regulation in cortical cells,
perhaps by activity-dependent factors. In turn, PC types in
most cortical layers showed a clear preference for Nrxn1
ASS2 splice-in, while some of the types in deeper layers dis-
played a preference for splice-out. An exception to the latter
was the L6b types, which showed a strong preference for
Nrxn1 ASS2 splice-in. This pattern may reflect additional sub-
tleties in the developmental origin of PCs (Pedraza et al.,
2014; Figures S2 and S3). In this manner, developmental origin
could define a base architecture for alternative splicing, which
can later be extended by activity-dependent or flexibly regu-
lated splicing in mature cells.
Finally, by examining neurexin splicing in embryonic Lhx6+-IN,
Prox1+-IN, and PC neurons (corresponding to medial ganglionic
eminence, caudal ganglionic eminence and/or preoptic area,
and pallial ventricular zone neurogenic origins, respectively),
we discovered three independent neurexin profiles, which
were generated embryonically. Although the functional rele-
vance of neurexins in embryonic neurons remains elusive, the
observed neurexin splice isoform profiles in immature embryonic
neurons were highly similar to those in mature cells derived from
that embryonic class. As a consequence, neurexin alternative
splicing in a developing cell is virtually independent of the cell’s
final identity or locale in mature brain. Thus, neurexin profiles are
virtually identical in cells that share a neurogenic origin, including
cells that (1) represent different cell types in the adult brain (e.g.,
PV-INs and SST-INs); (2) have migrated to different brain regions
during development (e.g., hippocampal and cortical PV-INs
(Figure S1); or (3) represent distinct subtypes of a major cell
type (e.g., in basket and dendrite-targeting PV-INs). Mutations
in neurexins have been implicated in neuropsychiatric and
autism spectrum disorders (S€udhof, 2017; Kasem et al., 2018),
and our results suggest a schema by which to understand
what cell types might be affected during pathologies, because
of the propagation of a mutation in an embryonic progenitor to
its descendant mature cell types.
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glutamate release (Gad1,Gad2, Slc17a1, Slc17a6, and Slc17a7) and developmental marker-gene expression (same as in Figure 1). INs were further classified on
the basis of developmental marker gene expression (Lhx6-Sox6 versus Prox1-Htr3a). Finally, expression of Sst, Ndnf, Reln, Lhx5, Trp73, and Calb2 was used to
delineate CR-ECs and PC-ECs. Cre lines used for cell collections are displayed above the heatmap.
(D) Violin plots show averaged gene expression levels for different embryonic neuron classes, as identified in (C).
(E) Bar plots show normalized Nrxn1 (upper panel) and Nrxn3 (lower panel) alternative splicing levels in mature versus embryonic Lhx6+ cells. Data represent the
mean and SEM. Statistical significances were calculated usingWelch’s t test on combined ‘‘splice-in’’ and ‘‘splice-out’’ data at each alternative splice site. There
were no significance levels below p = 0.1.
(F) Bar plots show normalized Nrxn1 (upper panel) and Nrxn3 (lower panel) alternative splicing levels in mature versus embryonic Prox1+ cells.
(G) Bar plots show normalized Nrxn1 (upper panel) and Nrxn3 (lower panel) alternative splicing levels in mature versus embryonic PCs.
(H) Regression analysis on the basis of neurexin alternative splicing levels between mature versus embryonic Lhx6+-INs.
(I) Regression analysis on the basis of neurexin alternative splicing levels between mature versus embryonic Prox1+-INs.
(J) Regression analysis on the basis of neurexin alternative splicing levels between mature versus embryonic PCs.
(K) Heatmap of correlation coefficients between mature and embryonic Lhx6+, Prox1+, and PC cell classes.
See also Figures S1–S6.
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EXPERIMENTAL MODELS AND SUBJECT DETAILS
Animals
All animal protocols and husbandry practices were approved by the Veterinary Office of Z€urich Kanton. The University of Zurich
animal facilities comply with all appropriate standards (cages, space per animal, temperature, light, humidity, food, water) and all
cages were enriched with materials that allow the animals to exert their natural behavior. Both males and females were used
for all experiments. To our best knowledge, we are not aware of an influence of sex on the parameters analyzed in this study. Animals
were sacrificed at embryonic E17.5-18.5 days.
Tissue from the following lines were used in this study:
1. Htr3a-Cre: B6.FVB(Cg)-Tg(Htr3a-cre)NO152Gsat/Mmucd, RRID:MMRRC_037089-UCD
2. Lhx6-Cre: B6;CBA-Tg(Lhx6-icre)1Kess/J Stock No: 026555
REAGENT or RESOURCE SOURCE IDENTIFIER
Critical Commercial Assays
SMARTer Ultra Low RNA Input v4 Takara Bio 634891
SMART-Seq HT kit Takara Bio 634438
Nextera XT DNA Sample Preparation Kit Illumina FC-131-1096
NextSeq 300 high-output kit Illumina 20024908
Deposited Data
Raw and analyzed data Tasic et al., 2016 GEO: GSE71585
Raw and analyzed data Tasic et al., 2018 GEO: GSE115746
Raw and analyzed data This paper GEO: GSE121653
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Mouse: Htr3a-Cre: B6.FVB(Cg)-Tg(Htr3a-cre)
NO152Gsat/Mmucd, RRID:MMRRC_037089-UCD
Gerfen et al., 2013 N/A
Mouse: Lhx6-Cre: B6;CBA-Tg(Lhx6-icre)1Kess/ The Jackson Laboratory Jax:026555
Mouse: Nex-Cre: NEX-Cre > < GM > <
Neurod6tm1(cre)Kan.
Goebbels et al., 2006 N/A
Mouse: Ai14: B6.Cg-Gt(ROSA)26Sor < tm14
(CAG-tdTomato)Hze >
The Jackson Laboratory Jax:007914
Software and Algorithms
STAR Aligner Dobin et al., 2013 https://github.com/alexdobin/STAR; RRID: SCR_015899
Trimmomatic Bolger et al., 2014 http://www.usadellab.org/cms/
index.php?page=trimmomatic; RRID: SCR_011848
Flexbar Dodt et al., 2012 https://github.com/seqan/flexbar; RRID: SCR_013001
samtools Li et al., 2009 http://samtools.sourceforge.net/; RRID: SCR_002105
HTSeq Anders et al., 2015 http://htseq.readthedocs.io; RRID: SCR_005514
Scikit-learn Pedregosa et al., 2011 https://scikit-learn.org; RRID: SCR_002577
scran Lun et al., 2016 http://bioconductor.org/packages/
release/bioc/html/scran.html; RRID: SCR_016944
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3. Nex-Cre: NEX-Cre > < GM > < Neurod6tm1(cre)Kan. > C57BL/6 background
4. Ai14: B6.Cg-Gt(ROSA)26Sor < tm14(CAG-tdTomato)Hze > /J Stock No: 007914
METHOD DETAILS
Electrophysiology and identification of cell types
Embryonic slices (400 mm thick) were prepared from E17.5-E18.5 mice, isolated from timed pregnant female mice, and incubated
at 34C in sucrose-containing artificial cerebrospinal fluid (sucrose-ACSF) (85 mM NaCl, 75 mM sucrose, 2.5 mM KCl, 25 mM
glucose, 1.25 mM NaH2PO4, 4 mM MgCl2, 0.5 mM CaCl2, and 24 mM NaHCO3) for 1 h, and then held at room temperature until
recording. Cells were visualized by infrared differential interference contrast optics in an upright microscope (Olympus; BX-51WI)
using Hamamatsu Orca-Flash 4.0 CMOS camera. Recordings were performed using borosilicate glass pipettes with filament
(Harvard Apparatus; GC150F-10; o.d., 1.5 mm; i.d., 0.86 mm; 10-cm length) at 33C in ACSF (126 mM NaCl, 2.5 mM KCl, 10 mM
glucose, 1.25 mM NaH2PO4, 2 mM MgCl2, 2 mM CaCl2, and 26 mM NaHCO3) with a standard intracellular solution (95 mM K-glu-
conate, 50 mM KCl, 10 mM HEPES, 4 mM Mg-ATP, 0.5 Na-GTP, 10 mM phosphocreatine; pH 7.2, KOH adjusted, 300 mOsm). All
recordings were made using MultiClamp700B amplifier (Molecular Devices), and signals are filtered at 10 kHz (Bessel filter) and
digitized (50 kHz) with a Digidata1440A and pClamp10 (Molecular Devices). Embryonic cells were identified by fluorescent labeling
in Lhx6-Cre::Ai14, Htr3a-Cre::Ai14 and Nex-Cre::Ai14 mice mice, at E17.5-18.5. Fluorescence-labeled cells were present in the
dorsal, medial pallium, and in the subpallium. Most cells were collected in the embryonic cortex.
Next-generation single-cell RNA sequencing
Sample collection
Methods and practices are as we described before (Fo¨ldy et al., 2016). To minimize interference with subsequent molecular exper-
iments, only a small amount of intracellular solution (1 ml; not autoclaved or treated with RNase inhibitor) was used in the glass
pipette during electrophysiological recordings. Before and during recording, all surface areas—including manipulators, microscope
knobs, computer keyboard, etc.—that the experimenter needed to contact during experiments were cleaned with RNase Away
solution (Molecular BioProducts). After recordings, cytosol was aspirated via the glass pipette used for recording. Although the
aspirated cytosol may have contained genomic DNA, our choice of cDNA preparation, which involved poly-A basedmRNA selection
virtually eliminated the possibility of genomic contamination in the RNA-seq data. For sample collection, we quickly removed the
pipette holder from amplifier head stage and used positive pressure to expel samples intomicrotubes containing cell collection buffer
while gently breaking the glass pipette tip. Cell collection microtubes were stored on ice until they were used.
cDNA library preparation
Same procedures were followed as we described before (Fo¨ldy et al., 2016). Single-cell mRNA was processed using Clontech’s
SMARTer Ultra Low RNA Input v4 or SMART-Seq HT kit. As first step, cells were collected via pipette aspiration into 1.1 mL of
10x collection buffer, spun briefly, and snap frozen on dry ice. Samples were stored at 80C until further processing, which was
performed according to manufacturer’s protocol. Resulting cDNA was harvested and analyzed on Fragment Analyzer (Advanced
Analytical). Library preparation was performed using Nextera XT DNA Sample Preparation Kit (Illumina) as described in the protocol.
Following library preparation, cells were pooled and sequenced using NextSeq 300 high-output kit in an Illumina NextSeq 500
System with 2x150 paired-end reads.
Bioinformatics
Processing of RNA sequencing data
After sequencing, raw reads were de-multiplexed and pre-processed using Trimmomatic and Flexbar. Then, raw sequencing reads
were aligned to the Ensembl GRCm38 reference transcriptome (Version-2015-06-25), using the STAR aligner with the following pa-
rameters: trimLeft = 10, minTailQuality = 15, minAverageQuality = 20 and minReadLength = 30. ’Single-end/paired-end’ and ’sense/
antisense/both’ options. Gene counts were calculated using HTSeq. For convenience, Ensembl gene IDs were converted to gene
symbols using the mouse GRCm38 gtf file (ftp://ftp.ensembl.org/pub//release-86/gtf/mus_musculus/Mus_musculus.GRCm38.86.
gtf.gz) as a reference. In the few cases where different Ensembl gene IDs identified the same gene symbol, average gene counts
were used. Altogether, expression of N = 22,800 genes were analyzed. This list was generated using Ensemble Biomart, with the
following specifications ‘‘Database=Ensembl Genes 85, Dataset=Mus Musculus genes (GRCm38.p4), Attributes=Ensemble Gene
ID and Associated Gene Name.’’
Online available RNA sequencing data
Original fastq files containing raw reads were downloaded from NCBI (GEO: GSE71585, GEO: 115746). All samples are from mice,
neuronal, and cell types are identified by molecular and electrophysiological markers in the original study (Tasic et al., 2018). Raw
sequencing reads for these samples were already pre-processed and de-multiplexed after sequencing.
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QUANTIFICATION AND STATISTICAL ANALYSIS
Quality control
For each cell, we calculated the total number of unique genes detected with at least 1 mapped read, and the number of mapped
reads. We then calculated the median and median absolute deviation of these 2 values across all cells. Cells that were more than
3 median absolute deviations below the median in either category were rejected as poor quality, otherwise they passed quality
control.
Normalization of gene expression
After quality control, cells (represented by raw gene count vectors) were pooled together and normalized using scran (Lun et al.,
2016), with sizes 40, 80, 120, 160, 200. Cell’s that had negative or zero size were removed. For further analysis, gene counts
were converted into log-space by the gi
0 = lnð1+ giÞ transformation, where gi was the normalized gene count of the i-th gene.
Mature cell sample numbers
We started with 20883 cells across 115 distinct cell types as labeled in the original paper (Tasic et al., 2018), of which 19439 passed
quality control (see section on ‘Quality Control’). Cell types were classified into the categories of Pyramidal Cells (55 cell types, 10748
cells), Prox1+-INs (28 cell types, 4559 cells) or Lhx6+-INs (31 cell types, 4065 cells) with the 67 cells in the Lamp5 Lhx6 cell type not
classified into any of the three categories.
Classification of embryonic cells
Wedevised an algorithm using Python classify embryonic cell types based on expression of specificmarker genes. The classification
was hierarchical; we first comparedGABAergic IN (IN-EC;markers:Gad1,Gad2 andSlc6a1) versus glutamatergic EC (gEC;markers:
Nrn1 (Putz et al., 2005), Slc17a6, Slc17a7, Neurod1 and Neurod2) class. In each embryonic cell, we evaluated two scores for each
class; the number of markers that were expressed, and the average expression of the 2 highest expressed markers. A categorical
marker was considered to be expressed, if it had an expression level higher than 0, and higher than the average expression of the
two highest expressed markers in that class minus 5. Based on these scores we classified all embryonic cells (N = 180) as either
IN-EC (N = 80), gEC (N = 73), or neither of these (N = 27). If the markers for only 1 class were expressed (for example, only IN, but
no gEC markers), and the average score of the two highest expressed markers was greater than 3, then the cell was classified as
a member of that class. In the case where markers for both classes were expressed, we compared the average scores of the
two highest expressed markers in either class. If one average score was higher than the other by 3 or more (e.g., gEC marker
average = 7 versus IN marker average = 2), the cell was classified as the class with the higher average score (gEC in this case). If
the difference in the average scores was less than 3 (e.g., gEC marker average = 4.9, IN marker average = 5.1), then we were unable
to unambiguously classify these cells as IN-EC or gEC and they were not further analyzed.
Next, we further classified IN-ECs into Lhx6+-expressing (markers: Lhx6, Satb1 and Sox6) and Prox1+-expressing (markers: Prox1,
Htr3a) EC categories. Similar to above, in each IN-EC we evaluated two scores for each class; the number of markers that were
expressed, and the average expression of the 2 highest expressed markers. Based on these scores we classified all IN-ECs (N =
80) as either Lhx6+-EC (N = 60), Prox1+-EC (N = 15), or neither of these (N = 5). If the markers for only 1 class were expressed,
and the average score of the two highest expressed markers was greater than 3, then the cell was classified as a member of that
class. In the case where markers for both classes were expressed, we compared the average scores of the two highest expressed
markers in either class. If one average score was greater than the other by 1 or more, the cell was classified as the class with the
higher average score. If the difference in the average scores was less than 1, then we were unable to unambiguously classify these
cells as Lhx6+-EC or Prox1+-EC and they were not further analyzed.
Next, we further subdivided gECs as PC-ECs (markers: Slc17a7, Neurod1 and Neurod2) versus Cajal-Retzius ECs (CR-ECs;
markers: Slc17a6, Nrn1, Ndnf, Reln, Lhx5, Trp73, and Calb2). Using the same scoring scheme as above (requiring expression of
at least 2 markers for CR-EC or at least 1 for PC-EC), we classified all gECs (N = 73) as either PC-EC (N = 46), CR-EC (N = 15), or
neither of these (N = 12).
During these calculations, all expression levels were converted to a log-2 scale with a pseudo count of 1 after normalizing the total
expression level of a cell to 1,000,000. Consequently, average refers to the geometric mean, a difference of 1 indicates a 2-fold
difference, a difference of 3 indicates an 8-fold difference and a difference of 5 indicates a 32-fold difference in expression levels.
Power analysis for RNA-seq data
To validate our neurexin splice isoform analysis, we compared cell type-specific single-cell qRT-PCR data from Fuccillo et al. (2015)
and single-cell RNA-seq data from Tasic et al. (2016), because both studies included matching PV and CCK cell type classifications.
To determine the number of single-cell RNA-seq datasets needed for statistically relevant comparisons to single-cell qRT-PCR data
(Figure S1), we calculated the signal-to-noise ratio (mean expression level over standard error of the mean; s.e.m.) of each
neurexin splice junction in the qRT-PCR data (range from 1.9 to 7.8) and took the median (5.2) as our target: targetsignal-to-noise =
median(qRT-PCRmean/qRT-PCRs.e.m.). We then calculated the signal-to-noise ratio of each splice junction in PV and CCK datasets
of the single-cell RNA-seq data (here, mean expression level over standard deviation, std, was used, because std does not factor
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for population size, which we actually aimed to determine): RNAseqsignal-to-noise = median(RNAseqmean/RNA-seqs.e.m.. From these,
we calculated how many cells would be needed to get the median signal-to-noise ratio equal to our target: cell_numberRNA-seq =
(target/RNA-seqsignal-to-noise)
2. We found that 214 PV and 70 CCK cells were needed from single-cell RNA-seq data to match the
power of single-cell qRT-PCR data.
Analysis of neurexin isoforms in single-cell RNA-seq data
For each cell, we calculated the expression levels of each splice junction (see Table S1 for specific nucleotide sequences) and the
number of reads aligning to each exon. Then, we normalized each splice junction expression level with cell size, and we normalized
the number of reads with cell size and with exon size. For analysis of alternative splicing, we calculated the expression levels of
canonical splice sites for each cell from the above determined normalized splice junction data, and used it to derive cell-type level
statistics.
We used a non-negative least-squares fit on the averaged exon expression levels to calculate the expression levels of each major
isoform (a, b, g forNrxn1, a and b forNrxn3) and predicted expression rate for each exon.We implemented a second order penalty for
drop out rates to avoid overfitting.
For alternative splicing data in Figure S1, we normalized each canonical splice site independently of the others. For each canonical
splice site, the total splice-in and splice-out level of each cell type was calculated, and the highest value was taken as a normalization
factor. This placed all splicing expression levels on a scale from 0 to 1 so that all canonical splice sites could be plotted together, while
preserving relative expression ratios between cell types.
For alternative splicing data in Figures 1, 4, and S3 for each canonical splice site, we divided each cell type’s splice-in and splice-
out levels by the total of the two values so that the plot would display the fraction of in and out splicing at each canonical splice site.
The average splice-in and splice-out levels at the cell type origin level were calculated by averaging the pre-normalization cell type
level values, and then applying the same normalization as above.
For isoform expression levels in Figures S1 and S7, we normalized by PV and mature levels respectively. For each gene and iso-
form, we divided both the PV and CCK levels (Figure S1) or mature and embryonic levels (Figure S7) by the normalization levels. All
statistical tests were performed using Student’s t test.
Dimension Reduction
Dimension reduction analysis was performed using the scikit-learn package (Pedregosa et al., 2011) for Python 3. Variables were
normalized using StandardScaler, and dimension reduction was done using PCA. The background was colored using a support
vector machine (svm, C = 1) trained on randomly selected half of the samples to avoid over fitting.
DATA AND CODE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE121653.
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Validation of neurexin alternative splicing analysis in single-cell RNAseq data 
(A) Comparison of Nrxn1, Nrxn2 and Nrxn3 expression. Bar plot shows normalized α and β and total 
counts across all cell types for Nrxn1, Nrxn2 and Nrxn3. Nrxn2 has a ~10 fold lower expression compared 
to Nrxn1 and Nrxn3 (Welch’s t-test, t-val=5.59, p=1.93x10-24). Data represent mean±s.e.m. (B) 
Quantification of splice junction covering reads. Table shows the % of cell types by cell class with at 
least 3 cells that had reads mapped onto the canonical splice site (either “splice-in” or “splice-out”). 
Missing values (Nrxn2 ASS6) represent cases where the gene did not possess the applicable canonical 
splice site. While all three genes had consistent expression, Nrxn2 splice junctions often had no reads 
mapped across entire cell types, making it inapplicable for our comparisons. (C) Comparison of cell 
type-specific marker genes between qRT-PCR and single-cell RNAseq. Using microfluidics-based 
single-cell quantitative RT-PCR (qRT-PCR), we had previously analyzed a subset of neurexin isoforms 
and canonical splice sites in PV and CCK interneurons in hippocampus (Fuccillo et al., 2015). We 
decided to compare the RNAseq data generated by the Allen Institute (Tasic et al., 2016, which included 
PV and CCK classified cell types) with these previously validated qRT-PCR probe sequences and results. 
Because the qRT-PCR data are hippocampal, while the RNAseq data contain mostly cortical PV and CCK 
cells, we could further ask if cortical and hippocampal neurexin profiles are similar. To accomplish this, 
we first wanted to validate that qRT-PCR can be directly compared with RNAseq results. To determine 
the number of cells to be used from RNAseq data that match power of qRT-PCR analysis, we performed 
power analysis and calculated the need for at least ~220 PV and ~70 CCK cells (see Methods). Because 
these numbers were close to the total PV and CCK numbers that were available in RNAseq data, we 
decided to analyze all the cells. We examined expression of marker genes that identify PV and CCK cells. 
Bar plots show averaged marker-gene expression for PV and CCK interneurons in single-cell qRT-PCR 
(sampled from hippocampus, left) and scRNAseq (sampled from cortex, right) data. The expression 
patterns of 11 out of 12 marker genes were virtually the same in the qRT-PCR (left) and scRNAseq (right) 
data. This suggested not only compatibility between qRT-PCR and RNAseq data, but consistent gene 
expression within PV or CCK types across brain regions. (D-E) Comparison of normalized Nrxn1 and 
Nrxn3 gene-expression levels for PV and CCK cells between single-cell qRT-PCR and RNAseq data. 
Bar plots show comparison of Nrxn1 and Nrxn3 α and β promoter usage between qRT-PCR (sample from 
hippocampus, left) and single-cell RNAseq data (sampled from cortex, right). For each gene, we 
normalized isoform levels to PV-levels. After calculating the isoform levels, we divided them and their 
errors by the corresponding PV levels so that each isoform had a normalized PV expression of 1. Thereby 
the plots display the ratios between the PV and CCK expression levels. We found nearly identical 
neurexin isoform profiles between hippocampal and cortical PV, and also between hippocampal and 
cortical CCK cells. (F) Comparison of normalized Nrxn1 and Nrxn3 alternative splicing levels for 
PV and CCK between single-cell qRT-PCR and RNAseq data. Bar plots show comparison of neurexin 
alternative splicing in Nrxn1 (top) and Nrxn3 (bottom) between single-cell qRT-PCR (left) and RNAseq 
(right) data. For each gene and canonical splice site, we calculated the total expression (both splice-in and 
splice-out) for each cell type. We then normalized the canonical splice site by this value, so that each 
splice expression could be fit on a scale from 0 to 1 while preserving the relative ratios between PV and 
CCK expression levels. For example, CCK cells have a significantly higher expression of Nrxn1α 
isoforms than PV cells. Consequently, Nrxn1 canonical splice sites ASS2, ASS3 and ASS4 which are 
unique to the α isoform have lower expressions in PV cells than CCK cells. Upward bars represent exon 
inclusion (“in”) and downward plots represent exon excisions (“out”). Remarkably, we found nearly 
identical neurexin isoform and splice site profile levels between hippocampal and cortical PV, and also 
between hippocampal and cortical CCK cells. Among the differences we detected were inclusion (“in”, 
48%) and excision (“out”, 52%) of Nrxn1-ASS2 exons in PV cells for hippocampal qRT-PCR, but 
complete excision (100%) in PV cells for cortical RNAseq data. (G) Relative levels of neurexin splice 
isoforms between specific GABAergic cell types is invariant between the cortex and hippocampus. 
We calculated an index of splice site inclusion versus exclusion for Nrxn1 and Nrxn3, defined separately 
for qPCR and for RNAseq as log10[(PVin/(PVin+out))/(CCKin/CCKin+out)]. Regression analysis performed 
on all non-zero neurexin splice isoform indices showed strong correlation (regression fit; R=0.90, 
p=8.4x10-4), further validating neurexin isoform analysis in single-cell RNAseq data, and demonstrating 
consistent expression of neurexin isoforms across different brain regions. These observations suggested 
that the relative level of neurexin isoforms between specific GABAergic cell types is invariant between 
the cortex and hippocampus, and that neurexin isoform expression patterns may overlap more broadly 
with cell type identity than previously envisioned. 
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Figure S2. (Related to Figure 1.)  
Exon junction usage of neurexins in mature cortical neurons 
(A) Cell type-level analysis of neurexin exon junction analysis. Canonical splice sites can have 
multiple potential alternative splicing variants, creating a more complex series of possibilities than a 
simple binary “in” or “out” option. Here we plot all relevant splice junctions for each canonical splicing 
site, labeled by how we classified them throughout the study as “splice-in” or “splice-out”. Rows 
represent exon-junctions and columns represent cell types. Circle colors represent expression levels on a 
log scale (right scale bar), while circle size represents portion of cells that an exon-junction was detected 
in (left scale bar). Where a canonical alternative splicing site has multiple exon-junctions classified 
together (as “in” or “out”), exon-junctions either have negligible expression (Nrxn1 ASS2-in ex7-ex6b), 
or their expression patterns show very strong correlations (Nrxn3 ASS3-in ex10-ex11 and ex11-ex12a), 
without any cell type-specific difference in their usage. As such all exon-junctions marking a single 
canonical splicing event are counted as one in the rest of the analysis.  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Figure S3. (Related to Figure 1.) 
Alternative splicing of Nrxn1 and Nrxn3 in mature cortical neurons 
(A) Cell type-level analysis of Nrxn1 and Nrxn3 alternative splicing. Bar plots show averaged and 
normalized alternative splicing of ASS1 through ASS6 of Nrxn1 and Nrxn3 in different PC, Prox1+ and 
Lhx6+ types. Bars are color-coded according to cell types on the top. For each cell type, exon inclusion 
(“in”) and exclusion (“out”) isoforms sum to 1. In cases of ASS1, ASS2 and ASS5 for both Nrxn1 and 
Nrxn3, and ASS4 for only Nrxn3 where alternative splicing involves multiple exons and mini-exons, 
detection of either exon “in” junction is counted as inclusion and specific detection of exon “out” junction 
is counted as exclusion. Averaged PC, Prox1+ and Lhx6+ type-level data are shown in Figure 1. Data 
represent the mean and s.e.m.  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Figure S4. (Related to Figure 1.) 
Co-expression of alternatively-spliced “in” and “out” neurexin isoforms in single cells 
(A-B) Detection rate of alternatively spliced exons in single cells. Alternatively spliced exon data from 
Nrxn1 (A) and Nrxn3 (B). Each row represents data for alternatively spliced exons, from ASS1 through 
ASS6, for each cell type. Cell types are labeled on top. The color code at the bottom represents the 
proportion of no exon detection, only exon “in”, only exon “out” and both exon “in” and “out”, within 
each cell type, as detected in single cells. 
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Figure S5. (Related to Figures 1, 2 and 3.) 
Cell type specific expression of neurexin splicing factors 
(A) Expression of splicing factors in PCs, Prox1+-INs and Lhx6+-INs. Violin plots show averaged 
gene-expression levels for different splicing factors, listed on left. We found enrichment of Khdrbs2 (also 
known as SLM-1) in PCs versus Lhx6+-INs and Prox1+-INs (Welch’s t-test: Lhx6+-IN vs PC Fold 
Difference=16.9, p-val<10-300, Prox1+-IN vs PC Fold Difference=5.3, p-val<10-300). SLM proteins are 
important for activity-dependent alternative splicing of neurexins at ASS4 (Iijima et al., 2011; 
Traunmüller et al., 2016) and are possibly further regulated at protein levels, to create cell type-specific 
neurexin splicing patterns. The significantly higher expression of Slm1 in PC versus Lhx6+-IN and 
Prox1+-IN cell types is consistent with our observation that PC but not Lhx6+-IN and Prox1+-IN cell types 
dominantly displayed exon excision at ASS4, which in part explains the measured neurexin patterns. (B-
D) Alternative splicing of neurexins correlates with neurogenic origin. These plots recapitulate those 
in Figure 3 with the added information that each data point is colored according to the cell type it 
represents (for color code see panel A). (B) PCA plot shows clear separation of cell classes based on 
developmental marker-gene expression (Neurod1 through Htr3a). Background color represents linear 
partitioning-based SVM classification. (C) PCA plot shows clear separation of cell classes based on 
neurexin alternative splicing (Nrxn1 and Nrxn3, ASS1 through ASS6). (D) PCA plot based on secreted 
neurexin ligands.  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Figure S6. (Related to Figure 1.) 
Exon-level expression of Nrxn1 and Nrxn3 in mature cortical neurons 
(A) Exon-level read counts in Nrxn1 and Nrxn3. In these plots, we display data as follows, each circle 
(or lack of thereof) represents averaged expression level for a given exon (numbers on top; 1 through 24 
for Nrxn1, left panel, and 1 through 25c for Nrxn3, right panel; alternatively spliced exons are highlighted 
with purple) and cell type (labeled on left). The start of Nrxn1 α, β and γ, and Nrxn3 α and β isoforms, 
which have different promoters, are displayed on top. Note that this plot technically displays only exon 
splice-in (“in”) information. Data representing exon-level expression (color code) and detection rate 
(circle size) are normalized separately by the highest data points found in Nrxn1 and Nrxn3, respectively, 
including all exon and cell types. Scale bar for expression level is shown on the upper right. Scale bar for 
detection rate is shown on the bottom right.  (B) The use of poly A-based mRNA does not result in 3’ 
bias in RNAseq results. Bar plots show averaged, across all cell types, normalized exon-level prediction 
rate counts for Nrxn1 (left) and Nrxn3 (right). We calculated the predicted expression rate of each exon 
based on reads aligned to each exon using a simple non-negative least squares fit, while adding a second 
order penalty for dropout rates to avoid over fitting. We detected all exons in both genes across 5’ through 
3’ ends evenly. Note that exons with a lower predicted rate are subject to alternative splicing (e.g. 6a and 
6b, in both genes). These suggest no significant 3’ bias, which is a possible, but not necessary, 
consequence of 3’ poly A-based mRNA selection (see also Tasic et al., 2016). 
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Figure S7. (Related to Figure 4.) 
Alternative splicing of neurexins in single embryonic neurons 
(A) Locale of embryonic cells. Dots represent sample approximate locations of cells (from Figure 4), 
color coded by cell class, in acute embryonic brain slices. Lhx6+-ECs (blue dots) were collected in dorsal 
pallium (isocortex, n=41), in subpallium (n=15) and in medial pallium (hippocampal allocortex, n=4). 
Prox1+-ECs (red dots) were collected in dorsal pallium (isocortex, n=12) and in medial pallium 
(hippocampal allocortex, n=3). PC-ECs (grey dots) were collected in dorsal pallium (isocortex, n=31) and 
in medial pallium (hippocampal allocortex, n=15). CR-ECs (black dots) were collected in dorsal pallium 
(isocortex, n=15). (B) Single-cell RNA sequencing quality parameters for embryonic neurons. Violin 
plots show sequencing and alignment parameters, including counts for reads, aligned reads, mapped 
reads, detected genes, as well as alignment and mapping rates. Each plot is labeled on the left and data 
points represent single cells. None of the parameters were different in any of the three cell classes. (C) 
Comparison of electrophysiologically-recorded vs. non-recorded cells. The alternative splicing of 
neurexins may change depending on neuronal activity levels (Iijima et al., 2011; Shapiro-Reznik et al., 
2012; Ding et al., 2017), and is possibly induced by electrophysiological recording. To evaluate, if 
electrical stimulation caused an up-regulation of activity-dependent genes and/or splice variants, we 
collected embryonic neurons either with (N=66 cells) or without (N=70 cells) electrophysiological 
recordings. We then used half of the cells from each group to select the 20 best separating genes (“training 
set”; using a chi-squared test), and used these genes to perform a PCA on the other half of the cells (“test 
set”). We did not observe a clear separation between electrophysiologically-recorded and non-recorded 
cells, indicating that electrophysiological recordings were not able to induce activity-dependent gene-
expression changes within the timeframe the cell cytosols were collected for RNAseq (usually within 5 
minutes). (D) Evaluation of cell-cycle stage in single embryonic neurons. Comparison of gene 
expression and alternative splicing in embryonic neurons could be compromised by the possibility that 
these cells were in different cell-cycle stages. To control for this, we used scran’s cyclone (Lun et al., 
2016), and found that 135 out of 136 cells were in the G1 phase, while 1 was in the G2 or M phase. We 
further plotted the cell cycle scores (3 scores per cell for G1, S or G2-or-M) to see if they clustered by cell 
class. We found no such clustering, suggesting that there were no differences in cell cycle stages. (E) 
Neurexin expression levels in single embryonic neurons. Bar plot shows normalized total counts across 
all cell classes for Nrxn1, Nrxn2 and Nrxn3. Nrxn2 expression was more than 10 times lower compared to 
Nrxn1 and Nrxn3. Data represent the mean±s.e.m. (F) Differential gene-expression between Lhx6+-EC, 
Prox1+-EC, and PC-EC classes. Volcano-plots show pairwise comparisons between the three cell 
classes. Differentially expressed genes (fold difference>4, adjusted-p<0.05) are plotted in orange, the rest 
in gray. The top five gene enriched in either comparisons are labeled for clarity. (G) Action potential 
spiking in single embryonic neurons. Bar plots show percentage of cells in Lhx6+-ECs, Prox1+-ECs and 
PC-ECs that elicited action potential spikes in response to depolarizing current injections. Standard errors 
were determined by modeling as binomial distributions to account for possible sampling variations in 
firing versus non-firing neurons in each group. Note that not all embryonic neurons were tested for action 
potential firing (Lhx6+-EC: 21 out of 60 cells were tested and 12 fired;  Prox1+-EC: 5 out of 15 cells were 
tested and 2 fired, CR-EC: 10 out of 15 cells were tested and 7 fired; PC-EC: 31 out of 46 cells were 
tested and all 31 fired). (H-J) Expression of neurexin α, β and γ isoforms in single embryonic 
neurons. Bar plot shows averaged and mature expression-normalized expression levels in Lhx6+-IN, 
Prox1+-IN and PC mature versus embryonic neurons. Data represent the mean and s.e.m. (K) Control 
regression analyses between unrelated mature and embryonic Lhx6+, Prox1+ and PC classes. In contrast to 
Figure 4H-J, these plots show that regression analysis based on neurexin splice isoform profiles between 
unrelated embryonic and mature cell classes results in poor correlation values with low significance. (L) 
Expression of splicing factors in single embryonic neurons. Heat map shows normalized gene 
expression levels for splicing factors, listed on left. Color represents normalized gene expression levels 
(scale bar is in lower left). (M) Expression level of Khdrbs genes (SLM proteins), which are 
implicated in the alternative splicing of neurexins. Bar plots show averaged Khdrbs (SLM) levels in 
Lhx6+-ECs, Prox1+-ECs and PC-ECs. Expression levels were not different between different cell classes 
(P>0.01 for all comparisons; Student’s t-test).  
Table S1 
Nrxn1 α
F/P/R TCCTCTTAGACATGGGATCAGG / CAACGGGATGGACGGTCAGGTA / GTGTAGGGAGTGCGTAGTG
GL 90630269@90642990
EJS GGGATGGACGGTCAG|GTAATTTAACAATTT TTGTCTTTGTAACAG|GTACCATTTCTGTCA
Nrxn1 β
F/P/R TGGCCCTGATCTGGATAGTC / ACCACATCCACCATTTCCAT / AATCTGTCCACCACCTTTGC
GL 90362942@90454805
EJS TGCGAGGCGGACACG|GTGGGTCTGCAATGC TCTTTTGTTTTACAG|CTGGGACAACATATA
Nrxn1 γ
F/P/R Not applicable (NA)
GL 90059564@90088164
EJS TGTGAAAACTCGCAG|GTAGCTTCTTCTCTC
Nrxn1 ASS1-in
F/P/R NA
GL 90704386@90991366 ; 90991379@90992114 ; 90992145@90995460 ; 90995476@91087954 
EJS AAAATAATGTAGTAC|CTTTACTTTTACCTA  TACCTTTACTTTTAC|CTATGCATTTGATGA 
EJS GAGCAGAGCCCATAC|CTTGGTCGCCCATCA TCAGGTGTGCCAGAC|CTTGAAGGGAAACAA
EJS GTAGAAAGCACCCAC|CTTCCACATTGTTGT CTTCCACATTGTTGT|CTTCTGAAAGCACAT
Nrxn1 ASS1-out
F/P/R NA
GL 90704368@90992114 ; 90991379@90995460 ; 90992145@91087954
EJS TATACTCTTCTTTTC|CTAGAAGAAAACAGA GAGCAGAGCCCATAC| CTTGGTCGCCCATCA
EJS TACCTTTACTTTTAC|CTATGCATTTGATGA  GTAGAAAGCACCCAC|CTTCCACATTGTTGT
EJS TCAGGTGTGCCAGAC|CTTGAAGGGAAACAA TCGGGCAGGCCTTAC|CTTGGCTGCAGTCCT
Nrxn1 ASS2-in
F/P/R ACTCAGGCATTGGACACG / CCAGCACAGCCGACCTTCCAG / ACAACCTCTTTGAGACAGCC
GL 90700906@90701966-90700906@90701987; 90702012@90704065
EJS CCCTTCTCCACAAAG|CACTCAGGCATTGGA AAACTACATTGTTCG|GTAGATATCATTCTA
Nrxn1 ASS2-out
F/P/R CTGCGTCAGGTGACAATATC / CCAGCACAGCCGACCTTCCAG / ACAACCTCTTTGAGACAGCC
GL 90700906@90704065
EJS CACTGATATTGTCAC|CTAGATGACAAAGCA CCACTGCGTTGTTAC|CTGACGCAGATTCCT
Nrxn1 ASS3-in
F/P/R AGCGTGCATATGGTATCCTG / TGAGTTTCACACGTCCTGCATCTAGC /  GCTGGATTACAGTTAATCCTGATAC
GL 90620892@90623419
EJS TTCTTCCCCATCTAG|ATTGTATCAGGATTA  TTAACTGTAATTCCA|GTAAGTGCCTATTCA
Nrxn1 ASS3-out
F/P/R AGCGTGCATATGGTATCCTG / TGAGTTTCACACGTCCTGCATCTAGC / AGGACCTTTGCCTAGATTGAC
GL 90597630@90623419
EJS TCTCAGGACCTTTGC|CTGTAGAATATGCCA GAAGGCCTGTTTTAC|CTAGATTGACCGTGA
Nrxn1 ASS4-in
F/P/R GTTGATGAATGGCTACTCGACAA / CACAATCTTCAATAGCCAAGCAACCATAA /  GCCATATTCAGAACTTTCAAGCC
GL 90162434@90163791; 90163882@90208322-90163882@90362759
EJS CTTTAAACTTTAAAG|GAAACAATGATAACG GGCTACTCGACAAAG|GTAAAAACATTGATT
Nrxn1 ASS4-out
F/P/R TACCCTGCAGGGCGTCA / CACAATCTTCAATAGCCAAGCAACCATAA / GCCATATTCAGAACTTTCAAGCC
GL 90162434@90208322
EJS TTGTGAGCTGACGCC|CTGTAAAAATAATAT CAAGCCCTTGCTTAC|CTGCAGGGTAGCGTT
Nrxn1 ASS5-in
F/P/R CGAGCTCAGGTGGGTTAGC / CTGGACTCCCGAATCACCTCTGC / CTGCGACAATCCCCACC
F/P/R CTCAGGTGGGTTAGCCAAC / CAGAGGTGATTCGGGAGTCCAGC / GAGGATGAGGATGCACAGAG
GL 90037385@90059475
EJS GCTCAGGTGGGTTAG|GTTAGTCAATTTTTT TCCTTTTTCCCACAG|CCAACCCCACCAGAG
Nrxn1 ASS5-out
F/P/R CGAGCTCAGCCAACCC / CAGAGGTGATTCGGGAGTCCAGC / GAGGATGAGGATGCACAGAG
F/P/R GCCGAGCTCAGGCCAACC / CTGGACTCCCGAATCACCTCTGC / CTGCGACAATCCCCACC
GL 90037385@90059484
EJS CTCTGGTGGGGTTGG|CTGTGGGAAAAAGGA ACTAACCTAACCCAC|CTGAGCTCGGCTCAC
Nrxn1 ASS6-in
F/P/R NA
GL 90560861@90561801; 90561829@90565304
EJS ATTTTGCTGACAAAG|TTGCATTGATGAAAG AAGCTGACTTGCAAG|GTAGATAGCCCTGTG
Nrxn1 ASS6-out
F/P/R NA
GL 90560861@90561505
EJS AGGTTGTGCTGGGCC|CTGTAAAATATTTCA CCCTGTCAAACGCAC|ATGTAAAAGGAGAGC
Nrxn3 α
F/P/R GGGAGAACCTGCGAAAGAG / CTGCCGTCATAGCTCAGGATAGATGC / ATGAAGCGGAAGGACACATC
GL 89260522@89348245
EJS GAACCTGCGAAAGAG|GTGCGTAGTATTTCT TTCTCTTTTTGGCAG|AGGCATCTATCCTGA
Nrxn3 β
F/P/R CACCACTCTGTGCCTATTTC / TCTATCGCTCCCCTGTTTCC / GGCCAGGTATAGAGGATGA
GL 89813641@89976346-89883892@89976346
EJS CTGTGTCTGGAAGTT|GTCCACCACACTTGG TCTTTCCCTTCACAG|CTGGTGCAACATACA
Nrxn3 ASS1-in 
F/P/R NA
GL 88795894@88832552 ; 88832565@88850278 - 88832571@88850278 ; 88850309@88853104 88853113@89187021
EJS AAATTGCTGCCACAG|ATGTCAGTCAAG|GTCCAGGTGAGTCTT
EJS TCCTCTCTTCCCCAG|GCCTCTCCCATCTTATGATGAGTGAACAAG|GTAGGTGCCTTGTGC
Nrxn3 ASS1-out 
F/P/R NA
GL 88795894@88850278 ; 88850309@89187021 - 88850309@89187029
EJS CACTCTGCTCAGAAG|GTAAGACCACCCTCT TCCTCTCTTCCCCAG|GCCTCTCCCATCTTA
EJS TGATGAGTGAACAAG|GTAGGTGCCTTGTGC GAGTATTACCTACAG|CACGAGAGGAGAACG
Nrxn3 ASS2-in 
F/P/R CAAAGTGACACGCAATCTTCG / CAGGCATCGGACACGCTATGGTAA / TTGAGTGTAGCCCGTTGTG
GL 89187324@89187858; 89191177@89193045
EJS TTCTTCTTCTCCCAG|TGTTATGTGAACCTC ATCGGACACGCTATG|GTAAACAAACTACAT
Nrxn3 ASS2-out  
F/P/R TTCGGCAGGTGACAATCTC / CCACAACGGGCTACACTCAAGAGG / CTGCGGTACTTGGGCTTC
GL 89187324@89193045
EJS CGCAATCTTCGGCAG|GTAATGGCCCGGGAA ATGTCCCACTACCAG|GTGACAATCTCTGTG
Nrxn3 ASS3-in 
F/P/R GATACACTGCGTCTAGAGTTGG / CTGTATCAGGATAAACTGTAACTCCAGC /  GTGTGCCACTCATTGTCATTG
GL 89348450@89354452; 89354480@89503017
EJS TTTTTCCCCATCTAG|ACTGTATCAGGATAA TAAACTGTAACTCCA|GTAAGTTTTTCCTCA
Nrxn3 ASS3-out
F/P/R GATACACTGCGTCTAGAGTTGG / TGGTTAACTTAGGCAAAGGACCTGAG /  GTGTGCCACTCATTGTCATTG
GL 89348450@89503017
EJS TCATGGTTAACTTAG|GTATCGTATGAAGGA TACCACCATTCTTAG|GCAAAGGACCTGAGA
Nrxn3 ASS4-in
F/P/R TCCCCTTCAAATATAACCGGC / AGCTAACCATCTTCAACACCCAGGC / ACGTCCTTTGTCCTTTCCTC
GL 90199224@90204498-90199237@90204510
EJS TTTTAAACTTTAAAG|GCAACACTGATAATG GGCTGCAGGAAAAAG|GTAACGGTCGTTAAA
Nrxn3 ASS4-out 
F/P/R AGAGAACTCCTGTCAATGATG / CAAATACCACGTTGTGCGCTTCACCAGGAATG /  TTAGCTGCCGGCCTGTA
GL 90169092@90204510
EJS AGCACTATCCTACAG|GTAACATCTTCCCTT CACCTAATCCACTAG|GCCGGCAGCTAACCA
Nrxn3 ASS5-in 
F/P/R GGCAATTCTATTTGTCCAAGAGC / ACATGCGGGCAATTTGTTGATGAGG /  GGGTAGCTAAAGGGTCTTCTAC
F/P/R
TGTCGAATGTGAACCAAGTA (β-specific) / GGTCAGGTCAACATTTTGCTCA (β-specific) /  
TGCTTTTTCTGTTGTTGTTG (β-specific)
GL 90283651@90321935-90283651@90321939-90283655@90321939-90283660@90321935-90283660 @ 90321939 || 90322642@90331484
EJS ATCCCTTCCTTACAG|CCAGAAGCTCTAATG GGGCAATTTGTTGAT|GTAAGTTGACTATAA
Nrxn3 ASS5-out
F/P/R ATGTGAACCAAGTACACAAACC / CGGAGCCAGGAATCAGACGGG / GAGGATCAAGATGCAGAGGG
GL
90283651@90322284-90283651@90322646-90283651@90331484-90283651@90331487- 
90283651@90331496-90283651@90331787-90283651@90331817-90283651@90332108- 
90283651@90332256-90283660@90331484-90283660@ 90331787-90283660@90332108
EJS GTGAACCAAGTACAG|GTAGGTCAGGTCAGT GTAATGTGCCCACAG|CAAACCCCACGGAGC
Nrxn3 ASS6-in
F/P/R NA
GL 89513113@89532890
EJS CTTTTGCTAACAAAG|TTGCGTTGACCAAAG AAGCTGACCTGCAAG|GTAGAGAAGGCTCTT
Nrxn3 ASS6-out 
F/P/R NA
GL 89517933@89532890; 89513113@89517905
EJS AGCGAGGCTGTGAAG|GTAGAACCTCTCTTC TTTGTGCACTACCAG|GACCCAGTACAACCT
Table S1. (Related to STAR Methods) 
Exon junction sequences and genomic locations for neurexin alternative splicing 
The identity and genomic location of different neurexin isoforms and alternative splicing outcomes were 
determined using specific sequences. These data are enlisted above. ‘F/P/R’ stands for ‘Forward / Probe / 
Reverse’ that refers to our previously validated Taqman assays (Fuccillo et al., 2015). These sequences are 
reported here as references, and are not changed compared to the original publication. ‘GL’ stands for 
‘genomic location’ that identifies the position of last and first exon nucleotides in exon junctions that 
identify specific isoforms and alternative splicing events. Locations are in End@Start format, where End 
and Start are the second and third values in STAR aligner –sj.out file. This indicates a splice site, where 
one exon ends at End-1, and the next exon starts at Start+1. For each alternatively spliced neurexin 
isoform, there are one or more genomic locations that define a splice variant or variants. Multiple variants 
occur when, for example, there are multiple potential acceptor sites only a few base pair apart, such as the 
case of Nrxn3 ss5-in, where the cassette exon has 2 splice acceptor sites (Chr12:90321935 and 
Chr12:90311939) from 2 splice donor sites (Chr12:90283651 and Chr12:90283655) which can generate a 
total of 4 combinations. Genomic locations with multiple variations follow the End1@Start1-
End2@Start2-End3@Start3- format, while multiple genomic locations are separated by a semicolon. For 
a splice variant that is defined by multiple genomic locations, the total expression of that variant is equal 
to the sum of the expressions of the genomic locations. For a splice site where multiple splice variants can 
be present, the expression of the alternatively spliced isoform is equal to the average expression of its 
splice variants. ‘EJS’ stands for ‘exon junction sequence’ that refers to nucleotide sequences identifying 
specific exon junctions. In each case, two exon-intron boundaries are displayed, as Start and End. For α, β 
and γ isoform and splice-out, sequences show the end and start of two flanking exons that define the 
isoform or splice site. For splice-in, sequences show the start and end of exon which incision define the 
splice site. Intron sequences are labeled in gray and italic, exon sequences are in color.
